This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report contains market size and forecasts of Phenylketonuria Treatment Product in global, including the following market information:
Global Phenylketonuria Treatment Product Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Phenylketonuria Treatment Product Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Phenylketonuria Treatment Product companies in 2021 (%)
The global Phenylketonuria Treatment Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Phenylketonuria Treatment Product include Biomarin, Mead Johnson, Abbott, Danone Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives and Firstplay Dietary. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Phenylketonuria Treatment Product manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phenylketonuria Treatment Product Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Phenylketonuria Treatment Product Market Segment Percentages, by Type, 2021 (%)
Medications
Supplements
Global Phenylketonuria Treatment Product Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Phenylketonuria Treatment Product Market Segment Percentages, by Application, 2021 (%)
Household
Hospital
Global Phenylketonuria Treatment Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Phenylketonuria Treatment Product Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Phenylketonuria Treatment Product revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Phenylketonuria Treatment Product revenues share in global market, 2021 (%)
Key companies Phenylketonuria Treatment Product sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Phenylketonuria Treatment Product sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biomarin
Mead Johnson
Abbott
Danone Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary